Dani Jadraque

Y esto? China tiene el 30% de su PIB via el gobierno, Francia 57% y los cretinos creen que es poco e inventan impuestos como este. Impuesto a los datos!!!

Doctors are taught to walk into a room, look at the patient and decide how sick they are. Ray Mak, a radiation oncologist at Mass General Brigham in Boston, calls that what it is: a subjective assessment. So his team turned it into a number. In a study published yesterday in The Lancet Digital Health, they trained an AI on more than 40 million photos of faces and then taught it two things: to estimate a person's biological age, and to predict how long a cancer patient will live from a single photo. Patients in the highest-risk quarter had more than three times the mortality of those in the lowest, even after adjusting for the usual clinical factors. In one test group of 3,820 patients, 64 of the 122 with the highest scores died within ninety days of the picture. Makeup, lighting, smiling or frowning didn't fool it. It is not ready for the clinic. The cancer model was trained mostly on white patients from the Boston area, and the hospital already has a patent pending. Matthew Liao, a bioethicist at NYU, warns that insurers or employers could use it. Fair point, but that is a question of rules about who gets to use the data, not a reason to stop the science. I spend my days building medical AI, and what strikes me is the cost. A blood test needs a lab, a nurse and a fridge. A face photo needs a phone that billions of people already carry. Some of the best biomarkers of the next decade may be the ones we already share every day without thinking. Your face has been telling doctors the truth for centuries. Now someone is finally taking notes.

Just realized George Church, who I know well and is the Harvard/MIT genetics legend, CRISPR pioneer, and one of the most important scientists alive, is raising for his gene therapy company Rejuvenate Bio on Wefunder. This is equity crowdfunding under Regulation CF. Everyday people (not just VCs or the ultra-rich) can invest as little as a few hundred dollars and own actual equity in a company spun out of his lab. One-shot AAV therapies that have already shown heart disease reversal in dogs, with years of safety data, and a path toward humans. For most of history, this kind of science was locked behind elite institutions and big checks. Now a founder of Church’s stature and his partners are deliberately opening the round to the broader community, and it’s working (oversubscribed, ranked #1 by Kingscrowd).